Bringing the Ocean to Society
19 Jul 2018
Do you work on the development of marine enzymes? This is for you!
INMARE wants to hear from researchers about how they are adapting to Access and Benefit Sharing (ABS).

The H2020  INMARE project is about marine biodiscovery and enzyme development. One of its focuses is the Nagoya Protocol and new regulations governing sampling and use of marine genetic resources for R&D in the EU. Now, the consortium is surveying how the Access and Benefit Sharing (ABS) Regulations are being implemented in Europe.

INMARE partner, the London School of Economics, is carrying out a short survey to establish how researchers are dealing with the implementation of the Nagoya Protocol in the EU, and the impact that this is having on their work.

If you work with genetic resources (e.g. nucleic acids, proteins, biochemical compounds, even bioinformatics data) then this will be relevant to you.

Maybe you are a young researcher and did not even know about this regulation, in which case you are certainly not alone!

INMARE wants to hear from everyone, the more responses received, the more robust the findings and the more impact INMARE will have.

Don’t struggle in silence! Help INMARE to help you and take this short 15 minute survey and have your voice heard.

COLUMBUS - a H2020 project finished earlier this year in which EurOcean and our Members VLIZ (Belgium) and Nausicaa (France) were deeply involved - had the goal to capitalise on the European Commission’s significant investment in marine and maritime research by ensuring accessibility and uptake of research Knowledge Outputs by end-users: policy, industry, science and wider society. COLUMBUS contributed to the creation of measurable value from research investments contributing to sustainable Blue Growth. One of the COLUMBUS Case Studies highlighted the importance of access and benefit-sharing of marine biological resources.